Acer Therapeutics Inc. / Fundamental strength relative to industry (Mohanram G-Value)

    The G-Value, developed by Mohanram in 2005, is a measure of a fundamental strength for growth companies. According to Mohanram, a low G-Value suggests a higher probability that a stock may be overvalued relative to its growth potential due to hype or overexcitement. The approach is described in detail in Mohanram's 2005 Paper Separating Winners from Losers among LowBook-to-Market Stocks using Financial Statement Analysis.

    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7
    Return on assets (ROA) greater than industry median
    close -346.3% ≤ -129.9%
    Operating cash flow over total assets greater than industry median
    close -277.2% ≤ -66.4%
    Operating cash flow greater than net income
    check -$33.11M > -$41.36M
    Variance in ROA over the last 5 years less than industry median
    close 95.7% ≥ 93.5%
    Variance in year-over-year sales growth over the last 5 years less than industry median
    close 101.3% ≥ 18.7%
    R&D expenses over total assets greater than industry median
    check 57.3% > 54.7%
    Capex over total assets greater than industry median
    check 1.0% > 0.6%

    G-Value history

    The G-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the G-Value at a specific time in the past.

    3
    3
    3
    2
    1
    2
    2
    1
    1
    1
    1
    1
    1
    1
    1
    3
    2
    2
    4
    3
    4
    4
    5
    3
    1
    2
    2
    2
    2
    2
    2
    2
    2
    2
    1
    3
    2
    1
    1
    1
    1
    1
    1
    1
    1
    3
    0
    3
    1
    2
    1
    3
    1
    1
    2
    3
    4
    5
    6
    7
    3
    4
    3
    2
    2
    2
    2
    1
    3
    2
    6
    4
    3
    4
    3
    2
    2
    4
    3
    3
    4
    5
    5
    5
    5
    4
    3
    3
    3
    3
    3

    Notifications